Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001654954-21-001676
Filing Date
2021-02-16
Accepted
2021-02-16 08:20:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT cambermygn-202013ga.htm SC 13G/A 60218
2 JOINT FILING AGREEMENT mygn13ga2020ex1.htm EX-1 4869
  Complete submission text file 0001654954-21-001676.txt   66683
Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108
Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600
MYRIAD GENETICS INC (Subject) CIK: 0000899923 (see all company filings)

EIN.: 870494517 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SC 13G/A | Act: 34 | File No.: 005-48577 | Film No.: 21632748
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199
Business Address 101 HUNTINGTON AVENUE SUITE 2101 BOSTON MA 02199 617-717-6600
Camber Capital Management LP (Filed by) CIK: 0001444043 (see all company filings)

EIN.: 421693587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A